Tag: glioblastoma

A family who lost their dad and husband to an aggressive brain tumour just days after diagnosis has shared how his influence lives on through his ‘life lessons’.

A mum-of-two who was diagnosed with an aggressive brain tumour seven years ago is crediting a positive mental attitude to helping her to navigate daily life alongside the condition.

If we can find a way to interrupt a cancer cell’s ability to keep dividing, we may have a key to stopping tumours growing. Researchers, Dr Wong and Dr Voon ,tells us about the discovery they made into a tumour’s ability to continuously divide.

New research shows that stem cells may be primed to activate. This early stage research could lead us to the reason glioblastomas recur so quickly.

Danielle Paparone and her boyfriend Jake, 24, were enjoying life in their native Australia when a shock diagnosis robbed Jake of his life and his loved ones of their dreams of what life with him would become.

A new publication from one of our research projects shines a light on the differences between the cells in the middle/core of a glioblastoma (GBM) compared to the cells spreading/infiltrating into healthy brain around the tumour.

Daniel shares his story of his brain tumour diagnosis and how his treatment and care has been affected by the ongoing coronavirus (COVID-19) crisis.

Actress reveals her family heartache as she becomes an ambassador for The Brain Tumour Charity to help raise awareness about brutal disease

Scottish scientist set to receive over £6 million from Cancer Research UK and The Brain Tumour Charity to find new ways to treat glioblastoma, one of the hardest types of cancer to treat.

Deputax-M failed to meet its target overall survival during an interim analysis of a phase 3 clinical trial in glioblastoma

Nivolumab, an immunotherapy drug, has been unsuccessful in improving overall survival in a phase 3 clinical trial when tested in newly diagnosed glioblastoma with unmethylated MGMT

A new type of drug that targets a particular protein could become the first ever treatment designed for children with diffuse midline gliomas (formerly known as DIPG)

Interviewed by our Young Ambassador, Grace Latter, Hal Cruttenden opens up about his mum’s diagnosis and why he supports the work we do

Researchers have discovered a new drug could potentially halt the spread of glioblastoma cells

A team of researchers have identified a new therapeutic target in glioblastoma cells that could halt the aggressive growth of this tumour type

Laboratory experiments show that a synthetic chemical is able to shut off glioblastoma cells’ energy source, leading to cell death

New data presented at the recent American Association of Clinical Oncology (ASCO) meeting in Chicago by Abbvie, a pharmaceutical company, provides hope for those diagnosed with a glioblastoma

The research engagement team recently visited The Blizard Institute of Cell and Molecular Science in London and met with Dr Tom Millner

A study led by researchers from Duke Cancer Institute identifies genetic markers to classify previously undetermined glioblastomas

Recent clinical data reports that a new surgical approach could improve survival for individuals with difficult to access high-grade gliomas

The new bank, announced today, will support and accelerate new research into brain cancer therapy

Researchers design immune cells to target a protein found on two thirds of glioblastomas, the most common and lethal primary brain tumour

Results of two phase 2 clinical trials testing cabozantinib suggest that anti-angiogenic therapy could be used to treat glioblastomas

Researchers at Massachusetts General Hospital prepare to launch a phase 1 clinical trial to test the combination therapy of hydroxyurea and temozolomide (TMZ)